Patent details
91089
Product Name:
IBRITUMOMAB
Basic Information
- Publication number:
- 91089
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
-
EP949014443
- Legal Status:
- Expired
- Application number:
- 91089
- First applicant's nationality:
- Procedural language:
- French
Marketing Authorization
- Marketing Authorization Number:
- eu/1/03/264/001
- Marketing Authorization Type:
-
- Marketing Authorization Date:
- 16/01/2004
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
-
Dates
- Filing date:
- 16/07/2004
- First Marketing Authorization date:
- 16/01/2004
- Grant date:
- 16/09/2004
- Activation date:
- 12/11/2013
- Publication date:
- 16/09/2004
- Lapsed date:
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 12/11/2018
- SPC Extension Expiration:
- 12/11/2018
- Rejection date:
- Withdrawal date:
Owner
- From:
- 11/06/2015
-
-
- Name:
- BIOGEN INC.
- Address:
- 225 BINNEY STREET, CAMBRIDGE, MA 02142, United States (US)
History of Owners
- From:
- 16/07/2004
- To:
- 10/06/2015
- Name:
- BIOGEN IDEC INC.
- Address:
- RESEARCH PLACE 5200, SAN DIEGO, CA 92122, United States (US)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 16/07/2004
- Address:
- PO Box 48, 8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
1
- Name:
- ANDERSON Darrell, R.
- Address:
- United States (US)
2
- Name:
- REFF Mitchell, E.
- Address:
- United States (US)
3
- Name:
- LEONARD John, E.
- Address:
- United States (US)
4
- Name:
- NEWMAN Roland, A.
- Address:
- United States (US)
5
- Name:
- HANNA Nabil
- Address:
- United States (US)
6
- Name:
- RASTETTER William, H.
- Address:
- United States (US)
Annual Fees
- Annual Fee Due Date:
-
- Annual Fee Number:
-
- Expected Payer:
-
- Last Annual Fee Payment Date:
- 29/05/2018
- Last Annual Fee Paid Number:
- 25
- Last Annual Fee Paid Amount:
- 450 Euro
- Payer:
- ENVOY INTERNATIONAL LIMITED
| Filing date |
Document type |
Number of pages |